(Q41970597)

English

In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).

scientific article published on May 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA). (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Larsson R

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

5

object named as

Nygren P

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

author name string

Fridborg H

2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Kristensen J

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Sundström C

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

language of work or name

0 references

publication date

1 May 1993

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

67

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

5

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

969-974

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1993.178

0 references

Clonogenic and nonclonogenic in vitro chemosensitivity assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

What is synergy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Mitoxantrone and etoposide: an effective regimen for refractory or relapsed acute myelogenous leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Mitoxantrone, cytosine arabinoside, and VP-16 in 36 patients with relapsed and refractory acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Synergistic interaction of anticancer agents: a cellular perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

5 June 2018

Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968433

18 August 2018

A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing chemotherapeutic combinations in the human tumor colony—forming assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro synergistic activity of PDN-IFN alpha and NM + IFN alpha combinations on fresh bone-marrow samples from multiple myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1993.178

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41970597&oldid=1558368838"